A Plea for Common Decency on Obesity
In his namesake show on HBO, Bill Maher recently claimed that “fat isn’t a birth defect” and “fat-shaming doesn’t need to end, it needs to make a comeback.”  Just a few days prior to this, in his viewpoint  published in Radio Times, Michael Buerk writes “Leave couch potatoes alone. They’re weak, not ill.” He goes on to argue that letting obese individuals die away will ultimately save the UK precious healthcare dollars. In doing so, Buerk humiliates, dehumanizes, and degrades the nearly 2 billion people around the world who are overweight or obese, many of whom are our colleagues, friends,…
Allurion’s tremendous success at IFSO 2019
It’s interesting to see how Allurion’s presence at IFSO has evolved within a few years, and how it reflects our growth. From walking and shaking hands in the aisles at Rio in 2016, in 2019 we welcomed huge crowds – all curious to know more about us and the Elipse Balloon in Madrid. Here’s a quick snippet of how Allurion sweeped the floor at IFSO 2019. Our IFSO journey started strongly this year, and we hosted our first expert symposium held on Thursday 5th September. Seven specialists shared their inputs on the Elipse Balloon Weight Loss Program: Dr. Ram Chuttani…
The Elipse Balloon in DietSpotlight
DietSpotlight recently wrote a comprehensive article on popular weight loss therapies and procedures. Here’s what they had to say about the Elipse Balloon: “The Elipse Balloon is the world’s first and only procedure-less intra-gastric balloon for weight loss. The balloon is swallowed in a capsule and filled with liquid in a 20-minute office visit. While in the stomach, the balloon is designed to help people feel full and encourage portion control. After four months, the balloon spontaneously opens, empties, and passes out of the body. The Elipse Balloon does not require surgery, endoscopy, or anesthesia for either placement or removal.”…
Allurion’s Shantanu Gaur on Jim Cramer’s Mad Money
Allurion Technologies founder discusses his company’s non-invasive ‘balloon’ pill that helps treat obesity from CNBC.
Why Stomach Balloons are the Future of Healthcare
The rise of the balloon field is not only revolutionizing obesity but also emblematic of shifts occurring in healthcare systems all around the world. Dr. Shantanu Gaur explores these themes in his latest post on MedCityNews. Click here for the full post.
Allurion Repays Massachusetts Life Sciences Center
5 years ago, the Massachusetts Life Sciences Center awarded us an Accelerator Loan that made the R&D and clinical testing possible for us to secure private investment. The loan program has helped countless companies grow and expand in Massachusetts. Today, we announce repayment of that loan! Thank you to the Center, Senator Karen Spilka, and Governor Charlie Baker for your support. We will continue to make Massachusetts proud!
Elipse Balloon Multi-Center Study Published
We are pleased to announce the publication of our European multi-center trial results in Endoscopy! Thank you to our European investigators and patients who participated in a groundbreaking study on the Elipse Balloon.
Obesity is Complex. Why Aren’t its Treatments?
In a recent article on MedCityNews, Dr. Shantanu Gaur and Michael Fergusson (CEO of Ayogo) explore the next generation of more personalized obesity treatments. Click here for the article.
Allurion Named Finalist in Lyfebulb-Novo Nordisk Innovation Summit
We were honored to be finalists at the Lyfebulb – Novo Nordisk Innovation Summit. Here is a video of our founder, Dr. Shantanu Gaur, presenting the Elipse Balloon to a packed crowd!
Allurion Technologies’ Elipse Intragastric Balloon Receives Prestigious SAGES Innovation Award
Allurion Technologies announced today that its flagship product, the Elipse Balloon, has received the prestigious Emerging Technology Innovation Award from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). The Elipse Device is the world’s first procedureless™ intragastric balloon: it is placed and removed without surgery, endoscopy or anesthesia. It is the first intragastric balloon to receive this award. The Elipse System received European Union CE marking in late 2015 and is now available at leading weight loss centers in the United Kingdom, Italy and France. Plans for commercial expansion within Europe and in the Middle East are underway. For the…